Evidence map›Paper›PMID 19298994›Full record

ArticleVirology2009

Control of viremia and maintenance of intestinal CD4(+) memory T cells in SHIV(162P3) infected macaques after pathogenic SIV(MAC251) challenge.

Bapi Pahar, Andrew A Lackner, Michael Piatak, Jeffrey D Lifson, Xiaolei Wang, Arpita Das, Binhua Ling, David C Montefiori, Ronald S Veazey

Open access · greenAbstract read
In one paragraph

Article in Virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Bapi PaharTulane National Primate Research Center, Tulane University School of Medicine, Covington, LA 70433, USA. bpahar@tulane.edu
Andrew A Lackner
Michael Piatak
Jeffrey D Lifson
Xiaolei Wang
Arpita Das
Binhua Ling
David C Montefiori
Ronald S Veazey
Tulane University · USScience Applications International Corporation (United States) · USDuke University · US

Funding

ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONSP51RR000164 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI VEAZEY, RONALD S. · 1985 to 2011
$100.1M
Topical Agents to Prevent Mucosal HIV TransmissionP01AI051649 · NIAID · UNIVERSITY OF GENEVA · PI LEDERMAN, MICHAEL MARCEL · 2002 to 2006
$7.5M
Evaluation of AFE Inhibitors for Protection from SHIV Vaginal ChallengeU19AI065413 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI MOORE, JOHN P · 2005 to 2007
$4.5M
Mechanisms of CD4 Depletion and Proliferation in SIVR01AI049080 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI VEAZEY, RONALD S. · 2001 to 2006
$2.2M
NCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400NCRR NIH HHS P51 RR000164NCRR NIH HHS RR00164NIAID NIH HHS AI49080NIAID NIH HHS P01 AI051649NIAID NIH HHS P01AI051649NIAID NIH HHS R01 AI049080NIAID NIH HHS U19 AI065413NIAID NIH HHS U19AI065413
6 · The paper itself

Abstract

Recent HIV vaccine failures have prompted calls for more preclinical vaccine testing in non-human primates. However, similar to HIV infection of humans, developing a vaccine that protects macaques from infection following pathogenic SIV(MAC251) challenge has proven difficult, and current vaccine candidates at best, only reduce viral loads after infection. Here we demonstrate that prior infection with a chimeric simian-human immunodeficiency virus (SHIV) containing an HIV envelope gene confers protection against intravenous infection with the heterologous, highly pathogenic SIV(MAC251) in rhesus macaques. Although definitive immune correlates of protection were not identified, preservation and/or restoration of intestinal CD4(+) memory T cells were associated with protection from challenge and control of viremia. These results suggest that protection against pathogenic lentiviral infection or disease progression is indeed possible, and may correlate with preservation of mucosal CD4(+) T cells.

Indexed as

Administration, IntravaginalAIDS VaccinesAnimalsCD4-Positive T-LymphocytesFemaleHIVImmunity, CellularImmunizationImmunologic MemoryIntestinesLymphocyte CountMacaca mulattaReassortant VirusesRNA, ViralSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAIDS VaccinesRNA, Viral

Identifiers

PMID19298994
PMCPMC2674129
OpenAlexW1969892766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.